'Intensified primary chemotherapy improved the outcome in poorer prognosis LABC T4 patients: results of a multicentric Italian study'

Autor: IONTA MT, ATZORI F, CARTA AM, CAPRA D, CONTU A, FARRIS A, CATINO AM, MINERBA L. MASSIDDA B., PALMERI, Sergio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::187e09ad9be990d335c2dcb699b10843
http://hdl.handle.net/10447/9987

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Autor: Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Inter-Hospital Pathology Division, Science and Technology Park, Institute for Research and Treatment Multimedica - IRCCS, Milan, Italy. Electronic address: giuseppe.pelosi@unimi.it., Papotti M; Department of Oncology, University of Turin, and Pathology Unit Molinette Hospital, City of Health and Science, Turin, Italy., Righi L; Department of Oncology, University of Turin, and Pathology Unit San Luigi Hospital, Orbassano, Turin, Italy., Rossi G; Division of Anatomic Pathology, Regional Hospital Umberto Parini, Aosta, Italy., Ferrero S; Division of Anatomic Pathology, Foundation for Research and Treatment - IRCCS Ca' Granda Major Hospital Polyclinic, Milan, and, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Bosari S; Division of Anatomic Pathology, Foundation for Research and Treatment - IRCCS Ca' Granda Major Hospital Polyclinic, Milan, and Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Calabrese F; Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy., Kern I; Department of Cytology and Pathology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia., Maisonneuve P; Division of Epidemiology and Biostatistics, European Institute of Oncology - IRCCS, Milan, Italy., Sonzogni A; Department of Pathology and Laboratory Medicine, Foundation for Research and Treatment- IRCCS National Cancer Institute, Milan, Italy., Albini A; Laboratory of Vascular Biology and Angiogenesis, Science and Technology Park, Institute for Research and Treatment (IRCCS) MultiMedica, Milan, Italy, and Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Harari S; Department of Medical Sciences and Division of Pneumology, San Giuseppe Hospital, Institute for Research and Treatment - IRCCS MultiMedica, Milan, Italy., Barbieri F; Oncology Unit, University Hospital Azienda Policlinico of Modena, Modena, Italy., Capelletto E; Department of Oncology, University of Turin, Thoracic Oncology Unit San Luigi Hospital, Orbassano, Turin, Italy., Catino AM; Medical Thoracic Oncology, Cancer Institute 'Giovanni Paolo II', Bari, Italy., Cavone D; National Mesothelioma Registry-Apulia Region, Regional Operational Center Cor Apulia, Occupational Health Division Bernardino Ramazzini, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy., De Palma A; Section of Thoracic Surgery, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy., Fusco N; Division of Anatomic Pathology, Foundation for Research and Treatment - IRCCS Ca' Granda Major Hospital Polyclinic, Milan, and, Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Lunardi F; Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy., Maiorano E; Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy., Marzullo A; Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy., Novello S; Department of Oncology, University of Turin, Thoracic Oncology Unit San Luigi Hospital, Orbassano, Turin, Italy., Papanikolaou N; Inter-Hospital Pathology Division, Science and Technology Park, Institute for Research and Treatment Multimedica - IRCCS, Milan, Italy., Pasello G; Medical Oncology 2, Department of Medical and Experimental Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Pennella A; Department of Surgery and Pathology, University of Foggia Medical School, Foggia, Italy., Pezzuto F; Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy., Punzi A; Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy., Prisciandaro E; Section of Thoracic Surgery, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy., Rea F; Thoracic Surgery Unit, Department of Cardiothoracic and Vascular Sciences, University of Padua, Padua, Italy., Rosso L; Division of Thoracic Surgery, Foundation for Research and Treatment - IRCCS Ca' Granda Major Hospital Polyclinic, Milan and Department of Health Sciences, University of Milan, Milan, Italy., Scattone A; Section of Pathology, Cancer Institute 'Giovanni Paolo II,' Bari, Italy., Serio G; Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari Aldo Moro, Bari, Italy.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2018 Nov; Vol. 13 (11), pp. 1750-1761. Date of Electronic Publication: 2018 Jul 07.

Behaviour of four serum tumor markers in pregnant women.

Autor: Correale M, Abbate I, Dragone CD, Tedone T, Musci MD, Gargano G, Catino AM, Bafunno AM, Grossi B

Publikováno v: The International journal of biological markers [Int J Biol Markers] 1993 Jul-Sep; Vol. 8 (3), pp. 198-9.

pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.

Autor: Correale M; RIA Laboratory, Oncology Institute of Bari, Italy., Abbate I, Paradiso A, Schittulli F, Dragone CD, Tedone T, Gargano G, Catino AM, Musci MD, De Lena M

Publikováno v: Cell biophysics [Cell Biophys] 1993 Jan-Jun; Vol. 22 (1-3), pp. 101-10.

Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone: Lorusso V, Pezzella G, Catino AM, Guida M, Scoditti S, Lorenzo R et al. Medical Oncology Division, Oncology Institute, Via Amendola 209, Bari 70126. Int J Oncol 1995;6:65–68

Publikováno v: In Lung Cancer 1995 12(3):307-307